On the other hand, the silencing of the ENPP2 gene or the treatment with α-bromomethylene phosphonate [BrP]-LPA, a pan-LPA inhibitor, inhibited this PTF trans differentiation and the consequent effects on HCC cells [85]. Here, LPA is linked to hepatocellular carcinoma.